Enjoy complimentary customisation on priority with our Enterprise License!
The global biomarkers market size is estimated to grow by USD 87.96 billion at a CAGR of 16.83% between 2023 and 2028. The market's growth is driven by factors such as the increasing prevalence of heart diseases, advancements in genomics and proteomics, and a growing focus on biomarker-based diagnostic methods. These trends highlight the demand for innovative diagnostic solutions to enhance patient care and outcomes. As heart diseases remain a leading cause of mortality globally, the market is poised for significant expansion. Efforts to leverage genomics and proteomics for personalized medicine and the development of advanced biomarkers further underscore the market's growth potential. Additionally, collaborations between healthcare providers and technology companies are likely to accelerate the adoption of these solutions, shaping the future of cardiac diagnostics.
To learn more about this report, Request Free Sample
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.